UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported):
(Exact name of Registrant as specified in its Charter)
(State or other jurisdiction of incorporation) |
(Commission File No.) |
(IRS Employer Identification No.) |
(Address of principal executive offices)
(Registrant’s Telephone Number)
(Former name or address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class | Trading symbol(s) | Name of each exchange on which registered | ||
OTC Pink |
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405)
or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2)
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act
Background.
This Amendment to Form 8-K filed November 18, 2022 informs investors that the USPTO has granted FOMO WORLDWIDE, INC. p/k/a FOMO CORP. a notice of allowance (“NOA”) for our trademark for “FOMO” regarding health and beauty beverages and canned drinks using nutraceuticals.
FOMO WORLDWIDE, INC. is referred to herein as “FOMO”, the “Company”, “we”, or “us”.
Item 8.01 Other Events.
Our trademark application for “FOMO” for health and beauty beverages and canned drinks using nutraceuticals passed the objection window that was initiated September 27, 2022 through publication on the USPTO Gazette and, effective November 22, 2022, our trademark application for “FOMO” for health and beauty beverages and canned drinks using nutraceuticals was granted a notice of allowance (“NOA”) by the USPTO. As a result, according to the USPTO, the trademark will be issued to us upon delivery of proof and plans for commercialization.
We are working with our minority investment Himalaya Technologies, Inc. (OTC: HMLA) to activate their co-pack agreement with Sprecher Brewing Co. and to formulate the beverage with FOMO’s and Himalaya’s minority investment GenBio, Inc. We intend to offer the product on a B2B basis through Sprecher’s 32-state distribution, through national retail distribution channels, and on a B2C and B2B basis through online channels including social media. Further information can be found below and in a press release we issued today included herein as Exhibit 10.1.
NOTICE OF ALLOWANCE (NOA)
ISSUE DATE: Nov 22, 2022
U.S. Serial Number: 97099373
Mark: FOMO
Docket/Reference Number:
No opposition was filed for this published application. The issue date of this NOA establishes the due date for the filing of a Statement of Use (SOU) or a Request for Extension of Time to file a Statement of Use (Extension Request). WARNING: An SOU that meets all legal requirements must be filed before a registration certificate can issue. Please read below for important information regarding the applicant’s pending six (6) month deadline.
SIX (6)-MONTH DEADLINE: Applicant has six (6) MONTHS from the NOA issue date to file either:
- An SOU, if the applicant is using the mark in commerce (required even if the applicant was using the mark at the time of filing the application, if use basis was not specified originally); OR
- An Extension Request, if the applicant is not yet using the mark in commerce. If an Extension Request is filed, a new request must be filed every six (6) months until the SOU is filed. The applicant may file a total of five (5) extension requests. WARNING: An SOU may not be filed more than thirty-six (36) months from when the NOA issued. The deadline for filing is always calculated from the issue date of the NOA.
Item 9.01. Exhibits
Exhibit No. | Description | |
10.1 | FOMO Worldwide, Inc. Press Release: USPTO NOA for “FOMO CAN” – November 22, 2022 | |
104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
FOMO WORLDWIDE, INC. | ||
Date: November 22, 2022 | By: | /s/ Vikram Grover |
Vikram Grover | ||
Chief Executive Officer |
Exhibit 10.1
FOMO WORLDWIDE ISSUED NOTICE OF ALLOWANCE FOR “FOMO CAN” BY USPTO
Chicago IL, November 22, 2022 – FOMO WORLDWIDE, INC.’s (OTC: FOMC) trademark application for “FOMO” for health and beauty beverages and canned drinks using nutraceuticals has been granted a notice of allowance (“NOA”) by the USPTO (U.S. Serial Number: 97099373). The trademark previously passed the 30-day objection window that was initiated September 27, 2022 through publication in the USPTO Gazette, which followed a one-year review process. As a result, according to the USPTO, the trademark will be issued to FOMO WORLDWIDE, INC. upon delivery of proof and plans for commercialization (i.e., “Statement of Use” or “SOU”).
FOMO is working with its minority investment Himalaya Technologies, Inc. (OTC: HMLA) to activate a signed co-pack agreement with a regional craft beer and soda manufacturer and to formulate the beverage with FOMO’s and Himalaya’s minority investment GenBio, Inc. (https://genbioinc.com/). We intend to offer the product on a B2B basis through our manufacturing partner’s 32-state distribution network which includes Big Box retailers, directly through major retail distribution companies, and on a B2C and B2B basis through online channels including social media.
Said Vik Grover, CEO: “The time-consuming process for trademark protection for FOMO CAN is nearing completion. I believe there is a significant market for a health drink that can combat inflammation and high blood pressure while providing non-caffeinated energy to consumers. The FOMO brand should resonate with customers seeking these benefits while adding nutrition to their diets ‘morning-noon-and-night’. We intend to trademark FOMO for other consumer facing products and services and explore international protections to further cement the brand’s sustainable value.”
Further information on the trademark and USPTO can be found at https://www.uspto.gov/.
About FOMO WORLDWIDE, INC.
FOMO WORLDWIDE, INC. (https://www.fomoworldwide.com/) p/k/a FOMO CORP. is a publicly traded company focused on business incubation and acceleration. The Company invests in and advises emerging companies aligned with a growth mandate. FOMO is developing direct investment and affiliations - majority- and minority-owned as well as in joint venture formats - that afford targets access to the public markets for expansion capital as well as spin-out options to become their own stand-alone public companies.
Forward Looking Statements
Statements in this press release about our future expectations, including without limitation, the likelihood that FOMO WORLDWIDE, INC. will be able to meet minimum sales expectations, be successful and profitable in the market, bring significant value to FOMO WORLDWIDE, INC.’s stockholders, and leverage capital markets to execute its growth strategy, constitute “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties and are subject to change at any time, and our actual results could differ materially from expected results. The Company undertakes no obligation to update or release any revisions to these forward-looking statements to reflect events or circumstances after the date of this statement or to reflect the occurrence of unanticipated events, except as required by law. FOMO’s business strategy described in this press release is subject to innumerable risks, most significantly, whether the Company is successful in securing adequate financing. No information in this press release should be construed in any form shape or manner as an indication of the Company’s future revenues, financial condition, or stock price.
Investor Contact
Investor Relations
(630) 708-0750
IR@fomoworldwide.com
Cover |
Sep. 27, 2022 |
---|---|
Cover [Abstract] | |
Document Type | 8-K/A |
Amendment Flag | true |
Amendment Description | Amendment No 1 |
Document Period End Date | Sep. 27, 2022 |
Entity File Number | 001-13126 |
Entity Registrant Name | FOMO WORLDWIDE, INC. |
Entity Central Index Key | 0000867028 |
Entity Tax Identification Number | 83-3889101 |
Entity Incorporation, State or Country Code | CA |
Entity Address, Address Line One | 1 E Erie St |
Entity Address, Address Line Two | Ste 525 Unit #2250 |
Entity Address, City or Town | Chicago |
Entity Address, State or Province | IL |
Entity Address, Postal Zip Code | 60611 |
City Area Code | (630) |
Local Phone Number | 708-0750 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common |
Trading Symbol | FOMC |
Entity Emerging Growth Company | true |
Elected Not To Use the Extended Transition Period | true |
;(]OA5^WEEA)I> !)ITK<0F6/A8WK"P@9BJ4A)O7Y!M<;;)F@[Q=**Y=
MB(O$Y+FP"5P@?XF:O90=T6G5 #3UL$J.K*<3;IRH8PI;ZQ63F]J_G6\VC;]Q
M%(K%13JV,O:6XF DT@*HU'IS9\X_(>/BB@>G4@(77 <'
MDIDJF8?APR.R:R4UP#E9$MXK5TE!2CA#*,!RD4K^=R+_1>)/N43)^DG>LG<6
M9,*VV/!\ W["QU].BZI-$]5]01)\*C"Z,77$+ZCPV)K"^S=S"/4^$
M>N8 O'4?<2:D+) I= ^@^TIP$'H^#]F-7CPK YP #H!6$99:.WTMX1TM53*7
M\>LX4%/R%DW/DOJ2@#^/#M'J61M1Z68#&)(+M$$ .9F7.7-<$=8^N!B+71FP
M*RM5@$30=W0>@8Q74\,(8U@;.K'=/BNP]=\;Z=7\'JV9-\GMTJ@T3 OH$E5/
M3VHLK*"2SA+W(BG1(%'[4\&^0Q'R8K%NA>;$2T_?5UUF%G.IK:I4&S)S)S5&R7]6_9L7X?K
MPI<8R-M,+P3P2=@0(88M<6$ H3F&Z3U&'1W5VZ3#J.^-X0=8,C N2C^TJ(N+
M=%MR]UX9OL(^K@\#6,S7YDYMKXQOL95:=F4HIFSTAZQD<+:DQR3C+J9J%B7H
M0$MT^#Q,/4Q>A8^';/)D*H6^"A^FMI*O6RPR8 ]K'NL;)ZE,EC1TRJ^*=SGO
M#,#K622] -,ZDV 'PV^8>'KBSR>3:;A)=VPVM@)Z['AGXG0G.
M\-_4A[^E7YCG,<3H@'S?'1V)(NMV$